This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Medifirst Solutions, Inc. Announces Further Update To Shareholders

Stocks in this article: MFST

BOCA RATON, Fla., March 20, 2013 /PRNewswire/ -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to welcome a distinguished and accomplished new member to the Medifirst Solutions Advisory Board. Says CEO Bruce J. Schoengood, "I am very pleased to announce that Fred Valdez, MD has joined the company Advisory Board." Dr. Valdez is a US army veteran who has served in the wellness industry for over 20 years. Continues Schoengood, "Dr. Valdez brings decades of knowledge, experience and relationships to Medifirst Solutions and we are honored to have him on our team."

Dr. Valdez is a radio host, author, musician and lecturer who brings with him a stellar resume and background. His extensive background includes:

--Graduate of  the University of Seville, Medical School.

--Trained at the University of Miami-Miami Jackson Memorial Hospital in trauma/ER.

--Worked at Memorial Hospital, Hollywood, Fl. for more than 12 years as house physician.

--Medical Program Chair at City College, Ft. Lauderdale, Fl.

--Medical Program Director, Everest University, Pompano Beach, Fl.

--Adjunct Professor of Nursing School, City College, Ft. Lauderdale, Fl.

--U.S. Army medical services veteran.

Dr. Valdez states, "I am a medical doctor who understands that for the most part, we practice 'reactive medicine.' I believe we need to use end explore better ways to provide healthcare through evidence based nutrition and supplementation rather than overmedication for a myriad of conditions. It makes more sense to prevent than to treat disease and conditions."  Medifirst Solutions is built around the idea that effective healthcare and wellness can be accomplished drug free and with new technologies and applications. "We share Dr. Valdez's philosophy and I am excited to have him on board. Furthermore, we anticipate additional members to be named to the Advisory Board in the upcoming weeks and months," states CEO Schoengood.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs